Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription Articles published in Dig Dis Retrieve available abstracts of 65 articles: HTML format

Single Articles

April 2024
1. TEUFEL A, Kudo M, Qian Y, Daza J, et al
   Current Trends and Advancements in the Management of Hepatocellular Carcinoma.
   Dig Dis. 2024 Apr 10. doi: 10.1159/000538815.
   PubMed     Abstract available
   
   
   March 2024
2. LEMMER P, Rohr LC, Henning M, Bulut K, et al
   Liver stiffness determined by transient elastography is a simple and highly accurate predictor for presence of liver cirrhosis in clinical routine.
   Dig Dis. 2024 Mar 25. doi: 10.1159/000538426.
   PubMed     Abstract available
   
   
   January 2024
3. WU PS, Hsieh YC, Lee PC, Yang TC, et al
   Mac-2 Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
   Dig Dis. 2024 Jan 12. doi: 10.1159/000535325.
   PubMed     Abstract available
   
   
   
4. MANSOUR N, Sirtl S, Angele MK, Wildgruber M, et al
   Management of Sinistral Portal Hypertension After Pancreaticoduodenectomy.
   Dig Dis. 2024 Jan 5. doi: 10.1159/000535774.
   PubMed     Abstract available
   
   
   
5. UOJIMA H, Sakaguchi Y, Gotoh K, Satoh T, et al
   Metabolic Dysfunction-Associated Fatty Liver Disease on Distinct Microbial Communities at the Bacterial Phylum Level.
   Dig Dis. 2024;42:61-69.
   PubMed     Abstract available
   
   
   
6. LI H, Yu S, Chen L, Liu H, et al
   Immunomodulatory Role of Mesenchymal Stem Cells in Liver Transplantation: Status and Prospects.
   Dig Dis. 2024;42:41-52.
   PubMed     Abstract available
   
   
   September 2023
7. TAN D, Chan KE, Wong ZY, Ng CH, et al
   Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of NASH between Males and Females.
   Dig Dis. 2023 Sep 13. doi: 10.1159/000533946.
   PubMed     Abstract available
   
   
   July 2023
8. KEKLIKKIRAN C, Stepanova M, Younossi Z, Yilmaz Y, et al
   Can Frequent Toothbrushing Reduce the Risk of Cirrhosis among Patients with Non-alcoholic Fatty Liver Disease? Hints from a Registry-based Study.
   Dig Dis. 2023 Jul 26. doi: 10.1159/000531981.
   PubMed     Abstract available
   
   
   June 2023
9. THORMANN M, Heitmann F, Wrobel V, Heinze C, et al
   Interstitial brachytherapy for hepatocellular carcinoma: Analysis of prognostic factors for overall survival and progression free survival and application of a risk stratification model.
   Dig Dis. 2023 Jun 29. doi: 10.1159/000531732.
   PubMed     Abstract available
   
   
   
10. TAMURA Y, Asaoka Y, Takeuchi A, Matsumoto K, et al
    Long-Term Prognosis and Related Factors in Patients with Cirrhosis Treated with Balloon-Occluded Retrograde Transvenous Obliteration.
    Dig Dis. 2023 Jun 29:1-9. doi: 10.1159/000530781.
    PubMed     Abstract available
    
    
    
11. CHEN Q, Zhong R, Wang Y, Kui Y, et al
    The Albumin-Bilirubin Score as a Predictor of Liver-Related Mortality in Primary Biliary Cholangitis with Compensated Cirrhosis.
    Dig Dis. 2023 Jun 15. doi: 10.1159/000531557.
    PubMed     Abstract available
    
    
    May 2023
12. QUEK J, Tan DJH, Chan KE, Lim WH, et al
    Quality Assessment of Ultrasound and Magnetic Resonance Imaging for Hepatocellular Carcinoma Surveillance: Systematic Review and Meta-Analysis.
    Dig Dis. 2023 May 11:1. doi: 10.1159/000531016.
    PubMed     Abstract available
    
    
    April 2023
13. WANG SQ, Zhan YQ, Hu X, Zhuang YP, et al
    Anemia is associated with disease severity, hepatic complications, and progression of Wilson disease: a retrospective cohort study.
    Dig Dis. 2023 Apr 5. doi: 10.1159/000530473.
    PubMed     Abstract available
    
    
    March 2023
14. GARCIA EM, Nerurkar SN, Tan EX, Tan SY, et al
    Characteristics and Outcomes of Elderly Hepatocellular Carcinoma Patients following Surgical Resection: Systematic Review and Meta-analysis.
    Dig Dis. 2023 Mar 13. doi: 10.1159/000530101.
    PubMed     Abstract available
    
    
    January 2023
15. SCHMIDERER A, Zoller H, Niederreiter M, Effenberger M, et al
    Liver transplantation after successful downstaging of a locally advanced hepatocellular carcinoma with systemic therapy.
    Dig Dis. 2023 Jan 16. doi: 10.1159/000529023.
    PubMed     Abstract available
    
    
    
16. QIAN Y, Liu B, Weiss C, Zhu X, et al
    Distance Matters: Correlation of Hepatocellular Carcinoma Nodule Distance to Overall Survival.
    Dig Dis. 2023;41:107-114.
    PubMed     Abstract available
    
    
    
17. CHENG P, Li Z, Fu Z, Jian Q, et al
    Small-For-Size Syndrome and Graft Inflow Modulation Techniques in Liver Transplantation.
    Dig Dis. 2023;41:250-258.
    PubMed     Abstract available
    
    
    
18. KREIMEYER H, Buechter M, Best J, Gieseler RK, et al
    Performance of the Liver Maximum Function Capacity Test, Fibrinogen, and Transient Elastography in Patients with Acute Liver Injury.
    Dig Dis. 2023;41:259-267.
    PubMed     Abstract available
    
    
    
19. WANG B, Min W, Zhang W, Liu Q, et al
    PIK3R3 Missense and NOTCH2 Synonymous Single Nucleotide Polymorphisms Are Associated with Liver Cancer.
    Dig Dis. 2023;41:458-467.
    PubMed     Abstract available
    
    
    
20. LIU W, Xu L, Xu F, Wang J, et al
    A Retrospective Analysis of the Efficacy of Endoscopic Variceal Ligation versus Endoscopic Tissue Adhesive Injection in the Treatment of Esophagogastric Variceal Bleeding.
    Dig Dis. 2023;41:468-475.
    PubMed     Abstract available
    
    
    
21. FERRARI-CESTARI M, Okano S, Patel PJ, Horsfall LU, et al
    Serum CC-Chemokine Ligand 2 Is Associated with Visceral Adiposity but Not Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Dig Dis. 2023;41:439-446.
    PubMed     Abstract available
    
    
    
22. PENG S, Wu Q, Huang X, He X, et al
    Diagnostic Value of Serum Golgi Protein 73 for Liver Fibrosis: A Systematic Review and Meta-Analysis.
    Dig Dis. 2023;41:622-631.
    PubMed     Abstract available
    
    
    
23. ITZEL T, Falconer T, Roig A, Daza J, et al
    Efficacy of Co-Medications in Patients with Alcoholic Liver Disease.
    Dig Dis. 2023;41:780-788.
    PubMed     Abstract available
    
    
    
24. LE MH, Henry L, Cheung R, Nguyen MH, et al
    Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis.
    Dig Dis. 2023;41:767-779.
    PubMed     Abstract available
    
    
    
25. ANDROUTSAKOS T, Dimitriadis K, Revenas K, Vergadis C, et al
    Liver Biopsy: To Do or Not to Do - A Single-Center Study.
    Dig Dis. 2023;41:913-921.
    PubMed     Abstract available
    
    
    
26. FU Z, Cheng P, Jian Q, Wang H, et al
    High Systemic Immune-Inflammation Index, Predicting Early Allograft Dysfunction, Indicates High 90-Day Mortality for Acute-On-Chronic Liver Failure after Liver Transplantation.
    Dig Dis. 2023;41:938-945.
    PubMed     Abstract available
    
    
    December 2022
27. HOU J, Qiang Z, Li Y, Zhang Y, et al
    The different prognosis of hepatocellular carcinoma with previous tenofovir vs entecavir treatment for chronic hepatitis B virus: analysis based on 15 propensity score-matched studies.
    Dig Dis. 2022 Dec 19. doi: 10.1159/000528711.
    PubMed     Abstract available
    
    
    November 2022
28. ZHANG Y, Cai H, Wu MH, Zhu DH, et al
    miR-3682-3p activated by c-Myc aggravates the migration and stemness in hepatocellular carcinoma cells by regulating PTEN/PI3K/AKT/beta-catenin signaling.
    Dig Dis. 2022 Nov 10. pii: 000527800. doi: 10.1159/000527800.
    PubMed     Abstract available
    
    
    October 2022
29. WANG X, Zhang J, Luo F, Shen Y, et al
    Application of CircRNA Circ_0071662 in the diagnosis and prognosis of hepatocellular carcinoma and its response to radiotherapy.
    Dig Dis. 2022 Oct 24. pii: 000527696. doi: 10.1159/000527696.
    PubMed     Abstract available
    
    
    
30. HONG C, Dong HZ, Li RN, Zhu HB, et al
    Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors.
    Dig Dis. 2022 Oct 18. pii: 000527574. doi: 10.1159/000527574.
    PubMed     Abstract available
    
    
    May 2022
31. CAO D, Liu H, Bai L, Tang H, et al
    EMT-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Hepatocellular Carcinoma.
    Dig Dis. 2022 May 30. pii: 000525232. doi: 10.1159/000525232.
    PubMed     Abstract available
    
    
    April 2022
32. OP DEN WINKEL M, Nagel D, Seidensticker M, De Toni EN, et al
    Development and external validation of the Munich Sorafenib Evaluation Score for hepatocellular carcinoma.
    Dig Dis. 2022 Apr 14. pii: 000524336. doi: 10.1159/000524336.
    PubMed     Abstract available
    
    
    March 2022
33. INUKAI Y, Yamamoto K, Honda T, Ito T, et al
    Differences in the intestinal microbiome associated with diarrhea during lenvatinib treatment for hepatocellular carcinoma.
    Dig Dis. 2022 Mar 28. pii: 000524298. doi: 10.1159/000524298.
    PubMed     Abstract available
    
    
    
34. SHI L, Zhang S
    Identification of subclasses of decompensated cirrhotic patients with acute kidney injury with different responses to fluid input.
    Dig Dis. 2022 Mar 17. pii: 000524028. doi: 10.1159/000524028.
    PubMed     Abstract available
    
    
    February 2022
35. JAHN M, Raschidi L, Ozcurumez MK, Arzideh F, et al
    Comparison of Mortality Prediction Scores in Intermediate-Care Patients with Liver Cirrhosis at a German university transplant Center; a prospective study.
    Dig Dis. 2022 Feb 16. pii: 000522595. doi: 10.1159/000522595.
    PubMed     Abstract available
    
    
    
36. YAN J, Deng M, Wang Y, Zhu M, et al
    Transjugular intrahepatic portosystemic shunt for portal vein cavernous transformation: a systematic review and single-arm meta-analysis.
    Dig Dis. 2022 Feb 7. pii: 000522313. doi: 10.1159/000522313.
    PubMed     Abstract available
    
    
    January 2022
37. MIJAC D, Krstic MN, Markovic AP, Popovic DD, et al
    Abnormal Liver Blood Tests: Primary Care Approach.
    Dig Dis. 2022;40:215-222.
    PubMed     Abstract available
    
    
    
38. SEHGAL R, Kaur N, Ramakrishna G, Trehanpati N, et al
    Immune Surveillance by Myeloid-Derived Suppressor Cells in Liver Diseases.
    Dig Dis. 2022;40:301-312.
    PubMed     Abstract available
    
    
    
39. GISZAS B, Weber M, Heidel FH, Reuken PA, et al
    Recurrent Upper Gastrointestinal Bleeding from Isolated Gastric Varices as Primary Symptom of Myelofibrosis: A Case Report on Combining Interventional and Pharmacologic Treatment Options.
    Dig Dis. 2022;40:530-534.
    PubMed     Abstract available
    
    
    
40. KALAL CR, Maiwall R, Choudhary A, Premkumar M, et al
    Mannitol Is Comparable to Hypertonic Saline for Raised Intracranial Pressure in Acute Liver Failure (MAHAL Study): A Randomized Controlled Trial.
    Dig Dis. 2022;40:607-615.
    PubMed     Abstract available
    
    
    
41. LEMMER P, Selbach N, Baars T, Porsch-Ozcurumez M, et al
    Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm.
    Dig Dis. 2022;40:644-653.
    PubMed     Abstract available
    
    
    
42. MASIOR L, Grat M
    Primary Nonfunction and Early Allograft Dysfunction after Liver Transplantation.
    Dig Dis. 2022;40:766-776.
    PubMed     Abstract available
    
    
    
43. GARRIDO I, Magalhaes A, Lopes J, Macedo G, et al
    Trastuzumab Emtansine-Induced Nodular Regenerative Hyperplasia: Is Dose Reduction Enough as a Preventable Measure?
    Dig Dis. 2022;40:787-792.
    PubMed     Abstract available
    
    
    
44. KAM LY, Huang DQ, Teng MLP, Takahashi H, et al
    Clinical Profiles of Asians with NAFLD: A Systematic Review and Meta-Analysis.
    Dig Dis. 2022;40:734-744.
    PubMed     Abstract available
    
    
    November 2021
45. SHAO X, Uojima H, Arai T, Ogawa Y, et al
    The risk of cirrhosis and its complications based on PNPLA3 rs738409 G allele frequency.
    Dig Dis. 2021 Nov 22. pii: 000521062. doi: 10.1159/000521062.
    PubMed     Abstract available
    
    
    
46. CHEN LS, Lee SW, Yang SS, Tsai HJ, et al
    Advances in the era of direct-acting antivirals for hepatitis C in patients with unresectable hepatocellular carcinoma.
    Dig Dis. 2021 Nov 9. pii: 000520721. doi: 10.1159/000520721.
    PubMed     Abstract available
    
    
    
47. DREWES R, Heinze C, Pech M, Powerski M, et al
    Apparent diffusion coefficient can predict therapy response of hepatocellular carcinoma to transcatheter arterial chemoembolization.
    Dig Dis. 2021 Nov 8. pii: 000520716. doi: 10.1159/000520716.
    PubMed     Abstract available
    
    
    October 2021
48. REITER FP, Ben Khaled N, Ye L, Zhang C, et al
    Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State of the Art Review.
    Dig Dis. 2021 Oct 13. pii: 000520095. doi: 10.1159/000520095.
    PubMed    
    
    
    July 2021
49. OSWALD L, Nakanishi H, Kurosaki M, Kirino S, et al
    Plasma renin activity predicts prognosis and liver disease-related events in liver cirrhosis patients with ascites treated by tolvaptan.
    Dig Dis. 2021 Jul 30. pii: 000518099. doi: 10.1159/000518099.
    PubMed    
    
    
    
50. JUNGST C, Justinger C, Fischer J, Berg T, et al
    Common ABCB4 and ABCB11 genotypes are associated with idiopathic chronic cholestasis in adults.
    Dig Dis. 2021 Jul 6. pii: 000518203. doi: 10.1159/000518203.
    PubMed    
    
    
    June 2021
51. OCAL O, Rossler D, Ricke J, Seidensticker M, et al
    Advances in Diagnostic and Interventional Radiology in Hepatocellular Carcinoma.
    Dig Dis. 2021 Jun 29. pii: 000518101. doi: 10.1159/000518101.
    PubMed    
    
    
    
52. KUBOTA K, Uojima H, Shao X, Iwasaki S, et al
    Additional L-carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin.
    Dig Dis. 2021 Jun 28. pii: 000518067. doi: 10.1159/000518067.
    PubMed    
    
    
    
53. OP DEN WINKEL M, Nagel D, de la Torre Alaez MA, Hempe S, et al
    A simple prognostic scoring system for hepatocellular carcinoma treated with selective internal radiation therapy.
    Dig Dis. 2021 Jun 10. pii: 000517458. doi: 10.1159/000517458.
    PubMed    
    
    
    May 2021
54. KRSTIC MN, Mijac D, Tomasevic RS, Lukic S, et al
    Abnormal liver blood tests: Hepatologist approach.
    Dig Dis. 2021 May 10. pii: 000517110. doi: 10.1159/000517110.
    PubMed    
    
    
    April 2021
55. MEYER JJ, Dreyhaupt J, Schwerdel D, Ettrich TJ, et al
    Blood-based targeted metabolomics discriminate patients with alcoholic liver cirrhosis from those with non-cirrhotic liver damage: an explorative study.
    Dig Dis. 2021 Apr 16. pii: 000516488. doi: 10.1159/000516488.
    PubMed    
    
    
    
56. MANZHALII E, Falalyeyeva TM, Moyseyenko VO, Weiskirchen R, et al
    Elevation of autoantibodies to cerebral proteins in hepatic encephalopathy: Another pathogenic factor?
    Dig Dis. 2021 Apr 9. pii: 000516412. doi: 10.1159/000516412.
    PubMed     Abstract available
    
    
    January 2021
57. WEBER S, Benesic A, Buchholtz ML, Rotter I, et al
    Antimitochondrial Rather than Antinuclear Antibodies Correlate with Severe Drug-Induced Liver Injury.
    Dig Dis. 2021;39:275-282.
    PubMed     Abstract available
    
    
    
58. XU Y, Hu X, Li J, Dong R, et al
    An Improved Scoring System Based on Platelet-Albumin-Bilirubin in Predicting Posthepatectomy Liver Failure Outcomes.
    Dig Dis. 2021;39:258-265.
    PubMed     Abstract available
    
    
    
59. WADA N, Uojima H, Satoh T, Okina S, et al
    Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease.
    Dig Dis. 2021;39:234-242.
    PubMed     Abstract available
    
    
    
60. PARK J, Lee EY, Li J, Jun MJ, et al
    NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea.
    Dig Dis. 2021;39:634-645.
    PubMed     Abstract available
    
    
    
61. YAMAMOTO K, Ikeya T, Okuyama S, Fukuda K, et al
    Association between the Frequency of Daily Toothbrushing and Development of Nonalcoholic Fatty Liver Disease.
    Dig Dis. 2021;39:646-652.
    PubMed     Abstract available
    
    
    
62. FREITAS M, Macedo Silva V, Xavier S, Magalhaes J, et al
    Early Kidney Dysfunction in Metabolic-Associated Fatty Liver Disease: Is Transient Elastography Useful as a Screening Method?
    Dig Dis. 2021;39:653-662.
    PubMed     Abstract available
    
    
    
63. ATTA S, Kamel M, Mansour W, Hussein T, et al
    Ascitic Fluid Cytokines in Chronic Liver Disease: A Possible Prognostic Tool.
    Dig Dis. 2021;39:534-539.
    PubMed     Abstract available
    
    
    November 2020
64. SCHINDLER P, Masthoff M, Harders F, Schmidt H, et al
    EFFICACY OF 90Y-RADIOEMBOLIZATION IN METASTATIC COLORECTAL CANCER DEPENDING ON THE PRIMARY TUMOR SIDE.
    Dig Dis. 2020 Nov 3. pii: 000512744. doi: 10.1159/000512744.
    PubMed     Abstract available
    
    
    September 2020
65. BARABAS L, Hritz I, Istvan G, Tulassay Z, et al
    The behavior of MMP-2, MMP-7, MMP-9 and their inhibitors TIMP-1, TIMP-2 in adenoma-colorectal cancer sequence.
    Dig Dis. 2020 Sep 22. pii: 000511765. doi: 10.1159/000511765.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.